Abstract
Amyotrophic lateral sclerosis (ALS) is a disease leading to neuromuscular transmission impairment. A2A adenosine receptor (A2AR) function changes with disease stage, but the role of the A(1) receptors (A1Rs) is unknown and may have a functional cross-talk with A2AR. The role of A1R in the SOD1(G93A) mouse model of ALS in presymptomatic (4-6 weeks old) and symptomatic (12-14 weeks old) phases was investigated by recording endplate potentials (EPPs), miniature endplate potentials (MEPPs), and quantal content (q.c.) of EPPs, from Mg(2+) paralyzed hemidiaphragm preparations. In presymptomatic mice, the A1R agonist, N (6)-cyclopentyladenosine (CPA) (50 nM), decreased mean EPP amplitude, MEPP frequency, and q.c. of EPPs, an effect quantitatively similar to that in age-matched wild-type (WT) mice. However, coactivation of A2AR with CGS 21680 (5 nM) prevented the effects of CPA in WT mice but not in presymptomatic SOD1(G93A) mice, suggestive of A1R/A2AR cross-talk disruption in this phase of ALS. DPCPX (50 nM) impaired CGS 21680 facilitatory action on neuromuscular transmission in WT but not in presymptomatic mice. In symptomatic animals, CPA only inhibited transmission if added in the presence of adenosine deaminase (ADA, 1 U/mL). ADA...Continue Reading
References
Jun 1, 1975·British Journal of Pharmacology·J A Ribeiro, J Walker
Jun 1, 1991·British Journal of Pharmacology·P Correia-de-SáJ A Ribeiro
Mar 1, 1987·The Journal of Physiology·J A Ribeiro, A M Sebastião
Jun 27, 1994·Brain Research·R A CunhaB B Fredholm
Jun 17, 1994·Science·M E GurneyH X Deng
Jul 22, 1993·Nature·D R Rosen
Nov 1, 1996·The Journal of Biological Chemistry·S A HawleyD G Hardie
Dec 1, 1996·Journal of Neurophysiology·P Correia-de-SáJ A Ribeiro
Jan 1, 1996·Progress in Brain Research·J A RibeiroA M Sebastião
Dec 22, 1999·Journal of Neurophysiology·L V LopesJ A Ribeiro
May 23, 2000·Journal of Neurochemistry·P Correia-de-SáJ A Ribeiro
Jun 5, 2002·Neuroscience·L V LopesJ A Ribeiro
Apr 7, 2004·British Journal of Pharmacology·Silvana De LorenzoAdriana Losavio
Feb 17, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Francisco CiruelaRafael Franco
Nov 6, 2007·TheScientificWorldJournal·Sergi FerréRafael Franco
Jun 11, 2009·British Journal of Pharmacology·Ana M Sebastião, Joaquim A Ribeiro
Jul 30, 2009·Handbook of Experimental Pharmacology·Ana M Sebastião, Joaquim A Ribeiro
Oct 1, 2009·The Journal of Pharmacology and Experimental Therapeutics·Paula A PousinhaJoaquim A Ribeiro
Oct 26, 2010·Neuroscience·A G PalmaA S Losavio
Mar 1, 2012·Neurobiology of Aging·Paula A PousinhaJoaquim A Ribeiro
Jul 5, 2012·PloS One·Sudhirkumar U YanpallewarLino Tessarollo
Jan 31, 2013·Journal of Neuroscience Research·Rosa Luisa PotenzaPatrizia Popoli
Feb 13, 2013·The Journal of Physiology·Andrea FuchsJochen Roeper
May 10, 2013·Purinergic Signalling·Sofia Cristóvão-FerreiraAna M Sebastião
May 18, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Fabrizio VincenziKatia Varani
Jun 29, 2013·Neuroscience·A TsentsevitskyR Giniatullin
Sep 17, 2013·PloS One·Mariana C RochaJoaquim A Ribeiro
Jan 31, 2014·International Journal of Molecular Sciences·Sandeep ShethVickram Ramkumar
Aug 6, 2014·PloS One·Filipe NascimentoJoaquim A Ribeiro
Oct 15, 2014·Nature Reviews. Neurology·Bart Swinnen, Wim Robberecht
Dec 3, 2014·Neurobiology of Aging·Karen S CoughlanJochen H M Prehn
Mar 18, 2015·Experimental Neurology·Seng Kah NgYongjie Yang
Citations
Sep 17, 2016·The Journal of Physiology·Danielle ArbourRichard Robitaille
Mar 21, 2017·CNS Neuroscience & Therapeutics·Mahshad Kolahdouzan, Mazen J Hamadeh
Apr 26, 2018·Frontiers in Pharmacology·Ágatha Oliveira-GiacomelliHenning Ulrich
Jul 28, 2018·Frontiers in Pharmacology·Konstantin A PetrovPatrick Masson
Feb 14, 2019·Neurochemical Research·Monica ArmidaRosa Luisa Potenza
Jun 15, 2017·Molecular Neurobiology·Carolina CunhaDora Brites
May 2, 2018·Frontiers in Pharmacology·Ana M SebastiãoJoaquim A Ribeiro
Nov 16, 2018·Purinergic Signalling·M CieślakM Wujak
Oct 11, 2017·Frontiers in Pharmacology·Geoffrey Burnstock
Mar 5, 2021·Life Sciences·Guzel F ZakyrjanovaAlexey M Petrov
Aug 28, 2021·Biomedicines·Akihisa MoriRobert Ristuccia